STAT

Banning direct-to-consumer drug ads won’t work

As a reformed hypochondriac, I’m extremely vulnerable to the allure of pharmaceutical ads. I self-referred for GLP-1s years ago after seeing advertisements, and even though I am a diabetic, what ...
Forbes

From Patients To Consumers: Direct-To-Consumer Pricing As A Model For Healthcare Reform

Correction, Sept. 9: The list price of Zepbound has been revised from an earlier version of this article. Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month ...
The Motley Fool

Why Did Direct-to-Consumer Retailers Stumble?

In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss: Why stocks of direct-to-consumer (DTC) companies have plunged. What omnichannel strategies have ...